Salesforce
CRM
Coinbase
COIN
Oracle
ORCL
4
Tesla
TSLA
5
Microsoft
MSFT
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Boston, MA.